Related Experiment Video

Updated: Aug 18, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling

I K Lund1, J A Hansen, H S Andersen

  • 1Signal Transduction, Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark.

Journal of Molecular Endocrinology
|April 12, 2005
PubMed

Insights

Protein tyrosine phosphatase 1B (PTP1B) directly dephosphorylates JAK2 and STAT3, terminating leptin signaling. This finding reveals PTP1B

Area of Science:

  • Cellular signaling pathways
  • Molecular mechanisms of hormone action
  • Signal transduction regulation

Background:

  • Leptin receptor activation initiates JAK/STAT signaling.
  • Protein tyrosine phosphatases (PTPs) are implicated as negative regulators of leptin signaling.
  • PTP1B deficiency confers resistance to obesity and enhances leptin signaling.

Purpose of the Study:

  • To elucidate the mechanism by which PTP1B terminates leptin signal transduction.
  • To investigate the direct role of PTP1B in dephosphorylating key signaling molecules.

Main Methods:

  • Co-transfection assays with PTP1B and a STAT3 reporter.
  • In vitro dephosphorylation assays using activated JAK2 and STAT3.
  • Utilizing a selective PTP1B inhibitor to assess leptin-induced STAT3 activation.

Main Results:

  • PTP1B dose-dependently inhibited leptin-induced STAT3 activation.
  • Catalytically inactive PTP1B or other PTPs did not inhibit STAT3 activation.
  • PTP1B selectively dephosphorylated JAK2 and STAT3 in vitro.
  • PTP1B inhibition enhanced leptin-induced STAT3 activation.

Conclusions:

  • PTP1B negatively regulates leptin signaling through direct dephosphorylation of JAK2 and STAT3.
  • This study identifies PTP1B as a key molecular switch in terminating leptin signal transduction.

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...